tiprankstipranks
Viracta Therapeutics (DE:RYI)
BERLIN:RYI

Viracta Therapeutics (RYI) Ownership - Who Owns Viracta Therapeutics?

0 Followers

Viracta Therapeutics (RYI) Ownership Overview

0.00%0.00%14.43%85.57%
14.43% Other Institutional Investors
85.57% Public Companies and
Individual Investors
The ownership structure of Viracta Therapeutics (DE:RYI) stock is a mix of institutional, retail and individual investors. Approximately 14.43% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 85.57% is owned by Public Companies and Individual Investors.
The ownership structure of Viracta Therapeutics (DE:RYI) stock is a mix of institutional, retail and individual investors. Approximately 14.43% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 85.57% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 04, 2023
Mark Rothera
President & Ceo,director
Bought$49000

Recent Hedge Fund Trading Activity

Currently, No Data Available
Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
379,246Insider377,350
84,259Insider83,838
30,708Insider30,554
5,623,815Insider5,595,696
133,740Insider133,071
4,659,333Insider4,636,036
1,050,000Insider1,044,750
23,452Insider23,335
1,096,410Institution1,177,544
63,591Institution68,297

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,674Institution1,798
46,234Institution49,655
5,920Institution6,358
34,562Institution37,120
1,210Institution1,300
12,430Institution13,350
238,901Institution256,580
74,000Institution79,476
1,096,410Institution1,177,544
28,450Institution30,555

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Viracta Therapeutics (DE:RYI)?
According to the latest TipRanks data, approximately 14.43% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 85.57% is held by retail investors.
    What percentage of Viracta Therapeutics (DE:RYI) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 14.43% of Viracta Therapeutics (DE:RYI) stock is held by institutional investors.
      What percentage of Viracta Therapeutics (DE:RYI) stock is held by retail investors?
      According to the latest TipRanks data, approximately 85.57% of Viracta Therapeutics (DE:RYI) stock is held by retail investors.
        Who owns the most shares of Viracta Therapeutics (DE:RYI)?
        Daniel Swisher owns the most shares of Viracta Therapeutics (DE:RYI).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis